Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Addition of GEN-1 to standard NAC shows safety and efficacy in phase I ovarian cancer study

Aug. 2, 2021

Jiangsu Simcere Pharmaceutical R&D discovers MAT2A inhibitors

Aug. 2, 2021

DNA-dependent protein kinase inhibitors discovered at Chengdu Baiyu Pharmaceutical

Aug. 2, 2021

Targeting hypoxia-induced metastatic genes shows therapeutic potential in uveal melanoma

Aug. 2, 2021

HA-121-28 studied in phase II for medullary thyroid carcinoma

July 30, 2021

New SERD discovered by dynamics simulation shows promise for breast cancer therapy

July 30, 2021

Reyoung divulges new autophagy inhibitors

July 30, 2021

New DNA-dependent protein kinase inhibitors identified at Chengdu Baiyu Pharmaceutical

July 30, 2021

Dizal (Jiangsu) Pharmaceutical discovers Bruton tyrosine kinase inhibitors

July 30, 2021

Blueprint Medicines and MD Anderson collaborate on advancing CDK2 inhibitor BLU-222

July 29, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...